AT-01 PHASE I TRIAL OF DOSE ESCALATED RADIOSURGERY PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA

BACKGROUND: Management of recurrent glioblastoma (rGBM) after standard initial therapy remains one of the most difficult challenges in oncology. Prior use of salvage stereotactic radiosurgery (SRS) for rGBM often involved maximum prescription doses defined by RTOG 90-05. We performed a prospective P...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Abbassy, Mahmoud, Missios, Symeon, Brewer, Cathy, Peereboom, David, Ahluwalia, Manmeet, Neyman, Gennady, Chao, Samuel, Suh, John, Barnett, Gene, Vogelbaum, Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2014
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217786/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak